BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 25, 2008
View Archived Issues
Recent Bayer Schering Pharma patents disclose novel contraceptive agents
Read More
Chelsea granted U.K. approval for phase II droxidopa trial in fibromyalgia
Read More
Dendreon expects interim data analysis for IMPACT trial in October 2008
Read More
GP Pharm completes phase III Lutrate trial in advanced prostate cancer
Read More
HT-0712 primate study reveals significant enhancement of long-term memory
Read More
Janumet approved in the E.U. for type 2 diabetes
Read More
MethylGene and Celgene temporarily suspend new enrollment in MGCD-0103 trial
Read More
ProQuin XR achieves first E.U. marketing authorization in Sweden
Read More
Medicure able to fund operations until the end of 2008
Read More
Teva's acquisition of Bentley Pharmaceuticals completed
Read More
Health Canada grants approval to Santhera's Catena in Friedreich's ataxia
Read More
Novel radiotracer useful for imaging CB1 type receptors in schizophrenia
Read More
Combined statin and biphosphonate treatment shows promise in mouse model of human progeria
Read More
[11C]-CUMI-101, a novel radioligand with potential use in imaging 5-HT1A receptors
Read More
Vitespen fails to improve recurrence-free survival in high-risk renal cell carcinoma patients
Read More
FDA issues nonapprovable letter in response to NexMed's NDA for a topical treatment for ED
Read More
New agents for treating psychiatric disorders reported in recent AstraZeneca and Abbott patents
Read More
New oncolytic agents imparted in recent patents
Read More
Ipsen presents an update on the company's acquisition of Tercica
Read More
Roche to acquire Arius Research
Read More
Santarus and Depomed enter U.S. promotion agreement for Glumetza for type 2 diabetes
Read More
Emergent BioSolutions and University of Oxford form joint venture to develop MVA-85A
Read More
FDA grants regulatory clearance to Response Biomedical to market Ramp NT-proBNP test for HF
Read More
OncoVista Innovative initiates enrollment in phase I/II study of cordycepin
Read More
Talecris' aerosolized alpha1-antitrypsin designated orphan drug in Europe
Read More
